Newly Awarded Grants

National Institutes of Health (NIH)

Exploratory/Development Grant
Title: Defining the Cellular Oncogenome of Kaposi Sarcoma
Principal Investigator: Ethel Cesarman MD,PhD
Period of Support: 08/01/2017 – 07/31/2019
Total Direct Costs: $273,529

The Daedalus Fund for Innovation

Research Grant
Title: Nucleoside Analogue Selectively Activated by Adenosine Kinase to Treat ADK-expressing Adenocarcinomas
Principal Investigator: Ethel Cesarman MD,PhD
Period of Support: 09/01/2017 – 08/31/2019
Total Direct Costs: $228,809

The Leukemia & Lymphoma Society

Mantle Cell Lymphoma Research Initiative
Title: Longitudinal functional genomics in mantle cell lymphoma therapy and drug resistance
Principal Investigator: Selina Chen-Kiang PhD
Period of Support: 01/01/18 – 12/31/22
Total Direct Costs: $2,083,330

American Society of Hematology

Bridge Grant
Title: Chromatin remodeling and FOXO in targeting CDK4 in mantle cell lymphoma
Principal Investigator: Selina Chen-Kiang PhD
Period of Support: 10/01/2017 – 09/30/2018
Total Direct Costs: $150,000

Tri-Institutional Therapeutics Discovery Institute

Title: Development of an Antibody Inhibitor of SLITRK5 for the Treatment of Osteoporosis
Principal Investigator: Matthew Greenblatt MD PhD
Period of Support: 6/1/17-5/31/18
Total Direct Costs: $54,951

March of Dimes

Basil O’ Connor Starter Scholar Research Award
Title: Defining the role of a Novel Periosteal Mesenchymal Stem Cell in Skeletal Morphogenesis and Development
Principal Investigator: Matthew Greenblatt MD PhD
Period of Support: 4/1/17-3/31/19
Total Direct Costs: $136,362

Doris Duke Charitable Foundation

Clinical Scientist Development Award (CSDA)
Title: Epigenetic landscapes of rearranged driver-negative cancers 
Principal Investigator: Marcin Imielinski MD PhD
Period of Support: 7/1/17-6/30/20
Total Direct Costs: $450,000

Tri-Institutional Therapeutics Discovery Institute

Title: Identification of Novel Therapeutics for Treatment of N-MYC Driven Castrate Resistant Prostate Cancer
Principal Investigator: David Rickman PhD
Period of Support: 6/1/17-5/31/19
Total Direct Costs: $200,000

United States Department of Defense

Title: Temporal Evolution of N-Myc Signaling and Early Targeting of the Neuroendocrine Phenotype in Prostate Cancer 
Principal Investigator: David Rickman PhD
Period of Support: 9/30/17-9/29/20
Total Direct Costs: $1,050,647

National Institutes of Health (NIH)

Specialized Program of Research Excellence
Title: Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
Principal Investigator: Mark A. Rubin MD
Period of Support: 8/30/17-7/31/22
Total Direct Costs: $7,097,925

National Institutes of Health (NIH)

Research Grant
Title: Discovering the molecular mechanisms that determine replicative lifespan
Principal Investigator: Jessica Tyler PhD
Period of Support: 09/30/2017 – 05/31/2021
Total Direct Costs: $1,430,388

National Institutes of Health (NIH)

Research Grant
Title: Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
Principal Investigator: Pengbo Zhou PhD
Period of Support: 01/17/2017 – 12/31/2021
Total Direct Costs: $1,679,989

Cullinogen, Inc

Sponsored Research Agreement
Title: Validation of CUL4B mAbs
Principal Investigator: Pengbo Zhou PhD
Period of Support: 01/27/2017 – 12/31/2018
Total Direct Costs: $173,913